Does neoadjuvant therapy improve outcomes in localised kidney cancer?
At the 2023 Society of Urologic Oncology (SUO) Annual Meeting, [...]
At the 2023 Society of Urologic Oncology (SUO) Annual Meeting, [...]
In this phase 3 randomised study, presented at the European [...]
Neoadjuvant therapy is the treatment given as a first step [...]
Just over half of the patients from a phase 2 [...]
Results from a phase 2 study were presented at the [...]
Results from the NeoAvAx clinical trial were presented at the [...]
The International Kidney Cancer Symposium (IKCS) 2021 took place in [...]
A recent phase 1 trial showed that treatment with nivolumab [...]
A recent retrospective study (looking back at the patients’ cases [...]
A retrospective study looked at the clinical and surgical outcomes [...]